Christine A. White

机构：The University of Texas MD Anderson Cancer Center

发表论文 43 篇 · 总被引 9311 次 · h-index 23

代表论文

• Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. (1998 · Journal of Clinical Oncology · 被引 2774)
• Randomized Controlled Trial of Yttrium-90–Labeled Ibritumomab Tiuxetan Radioimmunotherapy Versus Rituximab Immunotherapy for Patients With Relapsed or Refractory Low-Grade, Follicular, or Transformed B-Cell Non-Hodgkin’s Lymphoma (2002 · Journal of Clinical Oncology · 被引 1172)
• Treatment of Patients With Low-Grade B-Cell Lymphoma With the Combination of Chimeric Anti-CD20 Monoclonal Antibody and CHOP Chemotherapy (1999 · Journal of Clinical Oncology · 被引 861)
• Rituximab Anti-CD20 Monoclonal Antibody Therapy in Non-Hodgkin’s Lymphoma: Safety and Efficacy of Re-Treatment (2000 · Journal of Clinical Oncology · 被引 691)
• IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma. (1997 · Journal of Clinical Oncology · 被引 644)
• Phase I/II Trial of IDEC-Y2B8 Radioimmunotherapy for Treatment of Relapsed or Refractory CD20+B-Cell Non-Hodgkin's Lymphoma (1999 · Journal of Clinical Oncology · 被引 541)